June 6, 2024

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial – Nature.com

June 1, 2024

Staging and neoadjuvant response evaluation in patients with muscle-invasive bladder cancer (MIBC) using [18F]F-FDG PET/MRI – Journal of Nuclear Medicine

Staging and neoadjuvant response evaluation in patients with muscle-invasive bladder cancer (MIBC) using [18F]F-FDG PET/MRI

May 31, 2024

Bladder Cancer Treatment Advances: What’s the Latest? – Dana-Farber Insight

May 29, 2024

Q&A: Improved quality of life with bladder cancer advancements – Mayo Clinic

May 24, 2024

New Biomarker May Predict Treatment Response in Bladder Cancer – Feinberg News Center